Background Hepatocellular carcinoma has a high mortality rate due to its rate of recurrence.
Acyclic retinoid prevents recurrence of hepatocellular carcinoma in patients after surgical …

The recent discoveries of genomic and molecular markers in hepatocellular carcinoma
(HCC) have improved the understanding about the complexity of the signal transduction …

Genomic instability during hepatocarcinogenesis causes changes in signal transduction
network. Strategies for identification of new markers/therapeutic targets include discovery of …

Over the past 20 years, numerous tyrosine kinase inhibitors (TKIs) have been introduced for
targeted therapy of various types of malignancies. Due to frequent and increasing use …

Erlotinib was loaded on albumin nanoparticles for the first time and the cytotoxic effect of the
resulting nanoparticles against ASPC-1 and PANC-1 pancreatic adenocarcinoma cell lines …

The present study was undertaken to investigate the mechanisms of oridonin induced
apoptosis on human hepatocellular carcinoma BEL-7402 cells. BEL-7402 cells in culture …

Tissue factor (TF) is a transmembrane glycoprotein to initiate blood coagulation and
frequently overexpressed in a variety of tumors. Our previous study has showed that the …

AIM: To examine the underlying mechanisms of erlotinib-induced growth inhibition in
hepatocellular carcinoma (HCC). METHODS: Erlotinib-induced alterations in gene …

Introduction: The global incidence of hepatocellular carcinoma (HCC) is not expected to
decline significantly over the next 30 years. And although the latest gene sequencing …

Hepatocellular carcinoma (HCC) is a highly lethal disease, therefore effective and tolerable
treatment is urgently needed. In this article, we provide an updated review of the genetic …